Maxim Group Maintains Buy on SeaStar Medical Holding, Raises Price Target to $8
SeaStar Medical Beats Q1 Revenue Estimates, But EPS Miss Tempers Enthusiasm for ICU Stock
Full Transcript: SeaStar Medical Holding Q1 2026 Earnings Call
SeaStar Medical Holding Q1 EPS $(0.90) Misses $(0.82) Estimate, Sales $495.000K Beat $437.500K Estimate
SeaStar Medical shares are trading higher after the company announced the presentation of new SAVE Registry data and investigator-led research on the mechanism of action of the Selective Cytopheretic Device therapy.
SeaStar Medical Announces Positive Data From QUELIMMUNE SAVE Registy, And Availability Of New Research On Selective Cytopheretic Device Therapy
SeaStar Medical Holding Corp (NASDAQ:ICU) Beats Q4 Revenue and EPS Estimates, Shares Surge
SeaStar Medical Holding Q4 EPS $(0.80) Beats $(1.01) Estimate, Sales $420.000K Beat $372.500K Estimate
SeaStar Medical Completes Required Enrollment In FDA SAVE Registry TO Confirm Safety Of QUELIMMUNE Therapy Treatment For Children With Acute Kidney Injury Due To Sepsis
SeaStar Medical Publishes Data On Early Post-Approval Clinical Experience From Use Of QUELIMMUNE Device For Pediatrics Therapy
SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference
ICU: Critical Care Innovation for AKI Patients; Initiating Coverage of SeaStar Medical Holding Corp.
SeaStar Medical Announces 2026 Milestones
SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference
Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
SeaStar Medical Announces 1-for-10 Reverse Split
SeaStar Medical Holding shares are trading lower after the company announced a 1-for-10 reverse split.
SeaStar Medical Holding Announces 1-For-10 Reverse Stock Split, Effective January 5, 2026
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.